All News
Pts with hospitalization from #SLE often do NOT have a f/u visit within next 2 weeks. 2/3 NO timely fu esp poor, young non-White& do worse. Is it due to fact that no one gets discharge summary or admission note or discrimination or health system prob #abst0464 #ACR21 @RheumNow
Janet Pope Janetbirdope ( View Tweet)
Targeting the HUGE dilemma!🎯
#Psoriatic vs Erosive #OA
PsA
👉 Fluffy bone formation(enthesitis of phalanges)
👉 Marginal erosions(vs central)
👉 Many jts in same digit(ray inv)
👉 Periarticular SOFT tissue swelling (dactylitis).
👉 NOT much hand OA
#ACR21 RadiologyBootCamp https://t.co/OQLPoeRLny
Ashima Makol MD AshimaMakol ( View Tweet)
Abstract 0444- Dr. Gupta
⭐️COVAD Study - ❗️18000 global pt survey looking at AE after COVID vaccination in Autoimmune disease
1227 IIM pt total- more injection site pain, headache, rash, fatigue in DM
#ACR21 #ACRAmbassador https://t.co/s4Fc5c9Kln
Veena Katikineni VeenaRheumMD ( View Tweet)
Blood Brain Barrier leakage correlates w/ CNS dysfunction in SLE - study by John Hanley of 78 SLE pts. CNS impaired in 48% SLE (more likely LAC+, APL+) correlated w BBB (10-30%) leaks. #ACR21, Abstr# 0456 https://t.co/DyUB2TU4pS https://t.co/Sd1tr0BF2H
Links:
Dr. John Cush RheumNow ( View Tweet)
Also DESIR cohort: male gender & higher education independently assoc'd w/ lower hazard of Sick Leave (SL.) Older age & higher disease activity assoc'd w/ more SL. AxSpA dz activity & SES play roles in SL predictions. Abs 0380 #ACR21 #RheumNow @RheumNow https://t.co/1lRhDAu7Ug https://t.co/RRG6BeUqvs
Dr. Rachel Tate uptoTate ( View Tweet)
ARRIA Study: Abatacept vs PBO in pre-clincial RA (N98) pts x 6 mos. Showed ABA prevented arthritis (8 vs 35%), improved MRI inflamm (61 v 31%), fewer D/C (14 vs 43%) - all signif. Further FUV 12 mos off therapy still significant at 18mos #ACR21 Abstract 0455 https://t.co/ZxFUj6KfLT
Dr. John Cush RheumNow ( View Tweet)
Pearls on Rheum imaging:
👉CPPD is not erosive
👉SC joint in OA is common (hard to image)
👉AC joint is 1st place OA affects shoulders (not GH)
👉Neuropathic OA progress rapidly, look at the TMTs
👉Get more views if you aren't seeing what you need
#ACR21 Radiology Bootcamp
TheDaoIndex KDAO2011 ( View Tweet)
Another one from Dallas! Congrats, Dr. Limanni! #ACR21 https://t.co/Rs3muuFQKh
TheDaoIndex KDAO2011 ( View Tweet)
Dr Oster presenting on IL-23 inhibitor Risankizumab in PsA. No surprises here, it works. We need comparative efficacy trials! Abstr#0453 #ACR21 @RheumNow https://t.co/mj8TeCqEcg
Richard Conway RichardPAConway ( View Tweet)
Plenary I
0454 LN mortality in the US & disparities using CDC WONDER data 1999-2019
"LN mortality exhibited profound disparities by race/ethnicity and place of residence"
https://t.co/UtMzaiL14D
#ACR21 https://t.co/C3fuq8anvR
Rheum Cat rheum_cat ( View Tweet)
#ClinicalPearl What lasts longer/⬆️retention in sero+ RA: Abatacept or TNFi or JAKi? #ACR21 abst#0463 @RheumNow Adjusting for confounding incl line of Rx / past bio Rx, #abatacept wins. But data not stratified for bio naive or exposed. Not sure if that would alter results https://t.co/1dEQncwPQF
Janet Pope Janetbirdope ( View Tweet)
The best overall winner for the #ACR21 image competition https://t.co/Kr9EVAYVip
Rheum Cat rheum_cat ( View Tweet)
#ACR21 #ACR2021 #ACRLive
wonderful slide set to explain the spinal phytes https://t.co/5SxN7GeDzh
EnvisionRheumat ERheumat ( View Tweet)
#ACR21 Convergence Begins! Tune into our latest podcast where Dr. Cush reviews the news, and kicks off ACR21 learning and how to take in the annual meeting.
https://t.co/UnFiUR91vB https://t.co/NxVzeQbP4H
Links:
Dr. John Cush RheumNow ( View Tweet)
Factors that predict trajectories of radiographic progression in #axialspondyloarthritis 4 major patterns in the PSOAS cohort. Male gender, longer disease duration, raised CRP and smoking associated with higher spinal progression @RheumNow #ACR21 Abst#450 https://t.co/PvDE7T0MZp
Dr. Antoni Chan synovialjoints ( View Tweet)
Abst 0450 #ACR21 @RheumNow PSOAS cohort 4 trajectories of radiographic progression in AS: Non-progressors 37%, late-progressors 26%, early-progressors 19%, rapid-progressors 18%.⬆️ disease burden: male, longer disease duration & smoking . ⬆️eCRP=higher disease progression https://t.co/wUdBNzJPy0
Olga Petryna DrPetryna ( View Tweet)
Abst 0452 #ACR21 #acrbest @RheumNow TB-PET/CT in PsA helps differentiate from RA/OA &measure inflammatory burden. Main findings asymmetric synovitis,systemic enthesitis, DIP& extensor tendons inflammation& adjacent nail matrix inflammation, Sacroiliitis& diffuse spine enthesitis https://t.co/7nTSIbmKfE
Olga Petryna DrPetryna ( View Tweet)
ASRI data: high frequency of pregnancy and fetal complications (miscarriage, c-section, early delivery, NICU admission) in AxSpA pts. We need more studies regarding risks/tx/outcomes/breastfeeding guidance. Abs 0369 #ACR21 #RheumNow @RheumNow https://t.co/4BR2ZPPjyB https://t.co/qyTwtfEMMy
Dr. Rachel Tate uptoTate ( View Tweet)
#ClinicalPearl Leflunomide for chronic CMV retinitis failing antiviral Rx? Suppresses inflammation & Arava May have antiviral properties. Didn’t know it. Kolfenbach & Palestine 6S117 eye opening experiences #ACR21 @RheumNow
Janet Pope Janetbirdope ( View Tweet)
What increases risk of RA-assoc #bronchiectasis, separate from #RA-ILD?
Results from @BrighamResearch find seropositivity (esp high +ve RF/CCP), older age, disease duration, & low BMI incr. risk of isolated bronchiectasis in RA.
#ACR21 Abs#0288 @RheumNow
https://t.co/jvvRucqTjL https://t.co/aFCfxrbUdV
Mrinalini Dey DrMiniDey ( View Tweet)